Abstract:Purpose Sirtuin7 (SIRT7), as a member of the sirtuin and NAD + -dependent protein-modifying enzyme family, plays an important role in regulating cellular metabolism, stress responses, tumorigenesis, and aging. Ubiquitination and deubiquitination are reversible post-translational modifications that regulate protein stability, enzyme activity, protein–protein interactions, and cellular signaling transduction. However, whether SIRT7 is regulated by deubiquitination signaling is unclear. This study aims to elucidate the molecular mechanism of SIRT7 via deubiquitination signaling. Methods USP17L2 or SIRT7-targeting shRNAs were used to deplete USP17L2 or SIRT7. Western blot was applied to assess the effects of USP17L2 or SIRT7 depletion. A co-immunoprecipitation assay was used to detect the interaction relationship. Cell Counting Kit-8 assays were applied to assess the viability of breast cancer cells. An immunohistochemistry assay was employed to detect the protein level in samples from breast cancer patients, and the TCGA database was applied to analyze the survival rate of breast cancer patients. Statistical analyses were performed with the Student’s t test (two-tailed unpaired) and χ 2 test. Results We find that the deubiquitinase USP17L2 interacts with and deubiquitinates SIRT7, thereby increasing SIRT7 protein stability. In addition, USP17L2 regulates DNA damage repair through SIRT7. Furthermore, SIRT7 polyubiquitination is increased by knocking down of USP17L2, which leads to cancer cells sensitizing to chemotherapy. In breast cancer patient samples, high expression of USP17L2 is correlated with increased levels of SIRT7 protein. In conclusion, our study demonstrates that the USP17L2-SIRT7 axis is the new regulator in DNA damage response and chemo-response, suggesting that USP17L2 may be a prognostic factor and a potential therapeutic target in breast cancer. Conclusion Our results highlighted that USP17L2 regulates the chemoresistance of breast cancer cells in a SIRT7-dependent manner. Moreover, the role of USP17L2 as a potential therapeutic target in breast cancer and a prognostic factor for patients was elucidated.

MdmX is a substrate for the deubiquitinating enzyme USP2a

USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses

Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2

USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

MDMX Promotes Proteasomal Turnover of P21 at G1 and Early S Phases Independently Of, but in Cooperation With, MDM2.

USP22 Promotes NSCLC Tumorigenesis Via MDMX Up-Regulation and Subsequent P53 Inhibition.

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library

Critical Role for Daxx in Regulating Mdm2

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

Secondary Interaction Between MDMX and P53 Core Domain Inhibits P53 DNA Binding.

Mdm2 is A Negative Regulator of P21(Waf1/Cip1), Independent of P53

Ribosomal Protein S4 X-Linked as a Novel Modulator of MDM2 Stability by Suppressing MDM2 Auto-Ubiquitination and SCF Complex-Mediated Ubiquitination

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

USP9X Stabilizes BRCA1 and Confers Resistance to DNA‐damaging Agents in Human Cancer Cells

Deubiquitinase Ubiquitin‐specific Protease 9X Regulates the Stability and Function of E3 Ubiquitin Ligase Ring Finger Protein 115 in Breast Cancer Cells

Ubiquitin-specific Protease 2a Stabilizes MDM4 and Facilitates the P53-Mediated Intrinsic Apoptotic Pathway in Glioblastoma.

Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53

Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair.